stars 1 stars 2 stars 3

CerCell was founded 2009 to market the world only configurable Single-Use-Bioreactor portfolio for up-stream expression of antibodies and vaccine to the pharmaceutical industry. The focus is to supply end-users, contractors and Process-Control-System (PCS) manufacturers with creative, un-conventional, fully customisable, ready to use and visionary single-use products, such as: - Batch Single-Use-Bioreactor (SUB) for cultivation - Fed-batch Single-Use-Bioreactor (SUB) for cultivation - Single-Use-Fermenter (SUF) for fermentation - Single-Use-Mixer (SUM) for mRNA, viral vector, etc manufacturing - Perfusion SUBs incl Levitronix centrifugal pump World only supplier based on unique on-line "Configurator Tool" for SUB and SUF products. All products replacing any of the traditional glass/steel (STR). Scalable SUBs, SUFs, SUMs and P-SUBs ranging from 500 ml to 30 liter Vessel Volume. Easily controlled by existing PCS.

CerCell A/S Questions

The CerCell A/S annual revenue was $5.8 million in 2026.

Kevin Klejn is the CEO of CerCell A/S.

8 people are employed at CerCell A/S.

CerCell A/S is based in Herlev, Capital Region.

The NAICS codes for CerCell A/S are [33, 334].

The SIC codes for CerCell A/S are [382, 38].

G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users